[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362306-105":59,"doc-detail-362306-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancing-the-tumoricidal-efficacy-of-the-nanobubbles-mediated-pd-l1-inhibition-and-immunogenic-cell-death-in-mice","Enhancing the Tumoricidal Efficacy of the Nanobubbles-Mediated PD-L1 Inhibition and Immunogenic Cell Death in Mice","","Immunotherapy is a central focus for advanced hepatocellular carcinoma research, yet effective immune checkpoint modulation remains challenging. This study develops a nanobubble delivery system to co-administer an immunogenic cell death inducer, shikonin (SK), with the immune checkpoint regulator miR-497-5p. Thin-film hydration and mechanical oscillation produced miR-497/SK-loaded nanobubbles for in vitro and in vivo characterization and pharmacokinetic evaluation. In H22 hepatoma mice, ultrasound-triggered ICD (CRT, HMGB1) activates CD80+CD86+ macrophages, while miR-497 downregulates PD-L1, yielding strong tumor inhibition and systemic anti-tumor immunity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-the-tumoricidal-efficacy-of-the-nanobubbles-mediated-pd-l1-inhibition-and-immunogenic-cell-death-in-mice/362306/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-the-tumoricidal-efficacy-of-the-nanobubbles-mediated-pd-l1-inhibition-and-immunogenic-cell-death-in-mice/362306.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What therapeutic system was developed in this study?","Question",{"text":112,"@type":113},"The study developed miR-497/SK-loaded nanobubbles designed to co-deliver the immunogenic cell death inducer shikonin (SK) and the checkpoint-related miRNA miR-497-5p.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the nanobubbles prepared and evaluated?",{"text":117,"@type":113},"Nanobubbles were synthesized using thin-film hydration and mechanical oscillation to encapsulate miR-497 and SK. Characterization and pharmacokinetic analyses were performed in vitro and in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms explain the enhanced anti-tumor effect?",{"text":121,"@type":113},"Ultrasound-activated SK induces injury-related molecular patterns (CRT and HMGB1), promoting CD80+CD86+ macrophage activation and improved tumor antigen presentation. miR-497 then downregulates PD-L1, strengthening systemic anti-tumor immunity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362306,1790862337,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 09 January 2026  \nDOI 10.3389/fimmu.2025.1672324  \nOPEN ACCESS  \nEDITED BY  \nShue Wang,  \nUniversity of New Haven, United States  \nREVIEWED BY  \nAmal Babu,  \nChonnam National University Hwasun Hospital, Republic of Korea  \nYichi Chen,  \nThird Afﬁliated Hospital of Harbin Medical University, China  \n*CORRESPONDENCE  \nYu Hu  \n [1102692062@qq.com](1102692062@qq.com)[ ](1102692062@qq.com)Yun Zhao  \n [ZY_zhaoyun123@163.com](ZY_zhaoyun123@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 24 July 2025  \nREVISED 21 November 2025  \nACCEPTED 05 December 2025  \nPUBLISHED 09 January 2026  \nCITATION  \nLiu Y, Han J, Liu C, Chen Y, Yang S, Ma Y, Zhou C, Liu R, Hu Y and Zhao Y (2026) Enhancing the tumoricidal efﬁcacy of the nanobubbles-mediated PD-L1 inhibition and immunogenic cell death in mice.  \nFront. Immunol. 16:1672324 .  \ndoi: 10.3389/fimmu.2025.1672324  \nCOPYRIGHT  \n© 2026 Liu, Han, Liu, Chen, Yang, Ma, Zhou, Liu, Hu and Zhao. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEnhancing the tumoricidalefﬁcacy of the nanobubblesmediated PD-L1 inhibition and immunogenic cell death in mice  \nYun Liu 1†, Jiaxuan Han 2,3†, Chaoqi Liu 2,3, Yezi Chen 2,3, Shiqi Yang 2,4, Yao Ma 1, Chang Zhou 1, Rong Liu 1, Yu Hu 2,5* and Yun Zhao 2,3*  \n1 Department of Ultrasound Imaging, The First College of Clinical Medical Science, China Three Gorges University&Yichang Central People’s Hospital, Yichang, China, 2 Medical College of China Three Gorges University, Yichang, China, 3 Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China, 4 Department of Ultrasound Imaging, Afﬁliated Renhe Hospital of China Three Gorges University, Yichang, China, 5 Department of Ultrasound Imaging, Shaanxi Provincial People’s Hospital, Shaanxi, China  \nBackground: Immunotherapy becoming the focus of contemporary multidisciplinary collaborative research efforts towards advanced hepatocellular carcinoma (HCC) .  \nObjective: This study aims to develop a nanobubble (NB) delivery system designed to co-administer an immunogenic cell death (ICD) inducer, Shikonin (SK), alongside an immune checkpoint inhibitor, miR-497-5p, to enhance the efﬁcacy of the immune response against liver cancer.  \nMethods: NBs were synthesized through thin-ﬁlm hydration and mechanical oscillation techniques to encapsulate miR-497 and SK. Comprehensive characterization and pharmacokinetic analyses of the miR-497/SK-loaded NBs were conducted both in vitro and in vivo. To evaluate the anti-tumor efﬁcacy and immunological activity of this combination therapy, a subcutaneous transplanted tumor model using H22 hepatoma cells was established.  \nResults: The miR-497/SK-NBs demonstrated an optimal morphology and size, as well as excellent gene capacity and SK encapsulation. The in vivo anti-tumor effects and mechanisms of SK and miR-497 were assessed in H22 hepatoma transplants model. The miR-497/SK-NBs group showed the strongest tumor inhibition, with their synergistic immunotherapeutic effect demonstrated through two main mechanisms. Initially, the activation of SK, facilitated by ultrasound, triggered the induction of injury-related molecular patterns, including CRT and HMGB1 . This process subsequently activated CD80+ CD86+ macrophages, thereby enhancing the presentation of tumor antigens. Subsequently, miR-497 contributed to the down regulation of PD-L1 expression in tumor cells. Collectively, these processes elicited a robust systemic anti-tumor immune response and induced apoptosis in tumor cells ","cbCaijeORgy1lMcV","https://ap.wps.com/l/cbCaijeORgy1lMcV","pdf",26717647,16,"English","# Background\n# Objective\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What therapeutic system was developed in this study?\",\"answer\":\"The study developed miR-497/SK-loaded nanobubbles designed to co-deliver the immunogenic cell death inducer shikonin (SK) and the checkpoint-related miRNA miR-497-5p.\"},{\"question\":\"How were the nanobubbles prepared and evaluated?\",\"answer\":\"Nanobubbles were synthesized using thin-film hydration and mechanical oscillation to encapsulate miR-497 and SK. Characterization and pharmacokinetic analyses were performed in vitro and in vivo.\"},{\"question\":\"What mechanisms explain the enhanced anti-tumor effect?\",\"answer\":\"Ultrasound-activated SK induces injury-related molecular patterns (CRT and HMGB1), promoting CD80+CD86+ macrophage activation and improved tumor antigen presentation. miR-497 then downregulates PD-L1, strengthening systemic anti-tumor immunity.\"}]","Enhancing the Tumoricidal Efficacy of the Nanobubbles-Mediated PD-L1 Inhibition and Immunogenic Cell Death in Mice | PDF",1790147001,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc4890e239c4ad99906f6c2330ee1453.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee9068ba3505a1d503589f8a3bdd18bf.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3487d81274576b0469f60d38f7f4eb56.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7c889dcf902fa1713ce0aaaf7d47fc7.webp",980,1385]